VENATORX PHARMACEUTICALS
Venatorx Pharmaceuticals is a private company that focuses on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. The company was founded in 2010 and is headquartered in Malvern, Pennsylvania.
VENATORX PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2010-06-04
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.venatorx.com
Total Employee:
51+
Status:
Active
Contact:
610-644-8935
Email Addresses:
[email protected]
Total Funding:
165.72 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Truemeds
Truemeds is a health-tech startup that makes healthcare accessible to patients.
Vital Bio
Vital Bio is designing a new generation of tools to empower patients in monitoring health and managing the disease.
Current Advisors List
Current Employees Featured
Founder
Investors List
AMR Action Fund
AMR Action Fund investment in Series C - Venatorx Pharmaceuticals
Abingworth
Abingworth investment in Series C - Venatorx Pharmaceuticals
CARB-X
CARB-X investment in Grant - Venatorx Pharmaceuticals
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Venatorx Pharmaceuticals
Defense Threat Reduction Agency (DTRA)
Defense Threat Reduction Agency (DTRA) investment in Grant - Venatorx Pharmaceuticals
CARB-X
CARB-X investment in Grant - Venatorx Pharmaceuticals
Abingworth
Abingworth investment in Series B - Venatorx Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Venatorx Pharmaceuticals
BioAdvance
BioAdvance investment in Series B - Venatorx Pharmaceuticals
Foresite Capital
Foresite Capital investment in Series B - Venatorx Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2024-05-16 | Venatorx Pharmaceuticals Announces Changes to Executive Leadership |
| 2021-12-02 | Venatorx Pharmaceuticals Names Scott McConnell, Pharm.D. as Vice President, Medical Affairs |
Official Site Inspections
http://www.venatorx.com Semrush global rank: 10.45 M Semrush visits lastest month: 232
- Host name: 120.188.74.97.host.secureserver.net
- IP address: 97.74.188.120
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Venatorx Pharmaceuticals"
VenatoRx Pharmaceuticals | Antibacterial and Antiviral Drug R&D
Nov 11, 2023 · Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections …See details»
About - VenatoRx Pharmaceuticals
Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.See details»
Investors and Partners - VenatoRx Pharmaceuticals
Venatorx Pharmaceuticals has received equity investments from (in alphabetical order) Abingworth, the AMR Action Fund, BioAdvance, Foresite Capital and Verstant Ventures.See details»
Venatorx Pharmaceuticals - Crunchbase Company …
Venatorx Pharmaceuticals is a private company that focuses on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. The company was …See details»
Venatorx Pharmaceuticals, Inc. - LinkedIn
Venatorx Pharmaceuticals is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections...See details»
Venatorx Pharmaceuticals - Devex
Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat...See details»
Venatorx Pharmaceuticals - Org Chart, Teams, Culture & Jobs
View Venatorx Pharmaceuticals' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Venatorx Pharmaceuticals - Vivli AMR - amr.vivli.org
Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat …See details»
Pipeline - VenatoRx Pharmaceuticals
Venatorx Pharmaceuticals is pursuing novel chemical approaches to treat multi-drug resistant bacterial infections and hard-to-treat viral infections. Venatorx has built a world-class in-house research and development organization that has …See details»
VENATORX PHARMACEUTICALS, INC. - VentureRadar
VenatoRx Pharmaceuticals is a private pharmaceutical company dedicated to the discovery and development of novel agents to address the threat of antibiotic bacteria resistance. Its lead …See details»
Venatorx Pharmaceuticals Announces Collaboration …
Nov 1, 2021 · Venatorx Pharmaceuticals is a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with multi-drug-resistant bacterial infections and hard-to-treat...See details»
GARDP welcomes positive results in Venatorx phase 3 clinical trial …
Mar 10, 2022 · Venatorx Pharmaceuticals, Inc., a GARDP collaborator, today announced positive results from its pivotal phase 3 study evaluating cefepime-taniborbactam as a treatment for …See details»
CARB-X funds VenatoRx Pharmaceuticals to support the …
Nov 25, 2019 · VenatoRx is developing an oral penicillin-binding protein inhibitor (PBPi) to address the growing problem of resistance in Neisseria gonorrhoeae to the last resort …See details»
Board of Directors - VenatoRx Pharmaceuticals
Our board comprises blue-chip venture capital and seasoned life science executives.See details»
Venatorx Pharmaceuticals' Leadership Team - The Org
The leadership team at Venatorx Pharmaceuticals has a wealth of experience in the pharmaceutical industry, with members having worked for companies such as Protez …See details»
Venatorx Pharmaceuticals Raises Series C Financing Led by the …
Apr 4, 2022 · Venatorx is a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections and hard-to-treat viral …See details»
Venatorx Pharmaceuticals and Menarini Group Enter ... - Business …
Jan 9, 2024 · Venatorx is a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant gram-negative …See details»
History - VenatoRx Pharmaceuticals
Venatorx Pharmaceuticals was founded in June 2010 by our three visionary, fearless leaders Drs. Christopher J. Burns, Daniel C. Pevear and Luigi Xerri. We have established a world-class in …See details»
Venatorx - Overview, News & Similar companies | ZoomInfo.com
View Venatorx (www.venatorx.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Venatorx Pharmaceuticals Announces Collaboration with Roche to …
Malvern, PA, November 1, 2021 – Venatorx Pharmaceuticals announced today that it has entered into a Research Collaboration and License Agreement with Roche to discover, characterize …See details»